first_name,last_name,id,url,text,arg,Occupation score,Occupation score adjusted,Colby score,constituent_id,confidence,label,time,moved
Andrew,Davis,b'1778',http://www.rthk.hk/radio/radio4/programme/jazz_and_more/episode/532774,"Host: Kathy Lam 主持：林家琦 播出時間：逢星期一至五下午6時15分至8時 主持：林家琦 「不太古典」：一個結集爵士、古典、音樂劇、純音樂、日韓劇和電影原聲大碟音樂的節目。第一小時是爵士樂時段；第二小時有古典與「非古典」之作。為你的歸家路上添上色彩！ 1st Hour Dat Dere Art Blakey & Jazz Messengers My girl Donald Byrd Ordinary day Matt Bianco Let’s face the music and dance Diana Krall Over the rainbow Kenny Burrell 2nd Hour Claude Bolling: Concertante Yoyo Ma (vc), Claude Bolling (vc) DiLazzaro: Chitarra Romana Quartetto Gelato Schinfdler: Suite Americana Quartetto Chitarristico Ars Nova Tchaikovsky: Melodie from Souvenir d’un lieu cher Akiko Suwanai諏訪內晶子(v), Philip Moll (p) Ravel: Pavane pour une infante defunte Montreal SO/Charles Dutoit Tchaikovsky: Andante Cantabile Emerson String Quartet Faure: Pavane pour orchestre avec choeur, Op.50 Montreal SO and Cho./Charles Dutoit 17/10/2018 - 足本 Full (HKT 18:18 - 20:00) 17/10/2018 - 第一部份 Part 1 (HKT 18:18 - 19:00) 17/10/2018 - 第二部份 Part 2 (HKT 19:05 - 20:00) 17/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 16/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 15/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 12/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 11/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 10/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 09/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 08/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 05/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 04/10/2018 足本 Full (HKT 18:18 - 20:00) 第一部份 Part 1 (HKT 18:18 - 19:00) 第二部份 Part 2 (HKT 19:05 - 20:00) 1st Hour Pane Pintau Gavino Murgia Mediterranean Trio Green or blue Jorg Kaaig Quintet Soft shoe Fay Claassen Portriat of Jenny The Brussels Jazz Orch Everything I love Marc van Roon 2nd Hour Boccherini: Minuet Stuttgarter Kammerorchester/Karl Munchinger Elgar: Salute d’amor BBC Sym. Orch / Andrew Davis Saint-Seans: The Swan from Carnival of the Animals Jascha Silberstein (vc), Marie Goossens (harp) Villa-Lobos: Aria from Bachianas Brasileiras No. 5 Alexandre Lagoya (g), Academy of St. Martin-in-the-Fields/Kenneth Sillito Debussy: Clair de lune James Galway (f), Chamber Orch. of Europe / James Galway Nina Rota: The Godfather waltz City of Prague Phil / Nic Raine Ennio Morricone: Gabriel’s Oboe Yoyo Ma (vc), Roma Sinfonietta Orch. / Ennio Morricone Ennio Morricone: Cinema paradise Accademia Nazionale Italiana, Rome / Ennio Morricone John Williams: Theme from Schindler’s List Itzhak Perlman (v), Pittsburgh SO / John Williams (CD57403-00#2) Taro Hasake 葉加瀨太郎: The theme from the Last Emperor and empress 浦傑與王妃主題曲 Moscow Phil. Orch / Atsushi Yamada 16/10/2018 - 足本 Full (HKT 18:18 - 20:00) 16/10/2018 - 第一部份 Part 1 (HKT 18:18 - 19:00) 16/10/2018 - 第二部份 Part 2 (HKT 19:05 - 20:00) 新聞稿 | 招聘 | 招標 | 知識產權告示 | 常見問題 | 私隱政策 | 無障礙播放器 | © 2018 rthk.hk 網站獲奬:",0,0.0,0.0,0.0,1020357,0.9630101568145125,0,2018-10-17 13:58:55,False
Phillip,Frost,b'1777',https://reagentsglobalmarket.com/2018/10/16/present-fundamentals-eloxx-pharmaceuticals-nasdaq-elox/,"The long-term trend of the EPS is a vital number as it helps understand the future potential of Eloxx Pharmaceuticals. I will do my best to analyze this stock, but there is limited information, therefore please check back later by doing a search here or going to the tag page for the stock symbol ELOX here. The long-term trend in EPS shows how well the management of Eloxx Pharmaceuticals is adding value for shareholders. Eloxx Pharmaceuticals is part of the biotechnology industry and is part of the healthcare sector. The company CEO is Robert E. Ward. Eloxx Pharmaceuticals Inc is a United States-based clinical-stage pharmaceutical company. It is focused on building and developing a portfolio of therapeutics for the treatment of cancer and immunological diseases. The ELOX shares had a previous change of -2.75% which opened at 13.98 and closed at 13.45. It moved to an intraday high of 14.29 and a low of 12.53. SeekingAlpha: SEC charges against billionaire Phillip Frost may be ‘tip of the iceberg” – Barron’s Over the last five trading days, ELOX shares returned -10.27% and in the past 30 trading days it returned -21.94%. Over three months, it changed -24.69%. In one year it has changed 169.00% and within that year its 52-week high was 24.60 and its 52-week low was 3.90. ELOX stock is 244.87% above its 52 Week Low. Our calculations result in a 200 day moving average of 12.79 and a 50 day moving average of 15.28. Right now, ELOX stock is trading 5.15% above its 200 day moving average. SeekingAlpha: SEC charges against billionaire Phillip Frost may be ‘tip of the iceberg” – Barron’s The company has a market cap of $468.8m with 34.9m shares outstanding and a float of 15.5m shares. Trading volume was 42,036 shares and has experienced an average volume of 57,022 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock. The last annual reported EPS for Eloxx Pharmaceuticals was -8.35 which ended on 31st of December 2017. Based on 2 analyst estimates, the consensus EPS for the next quarter is -0.35. Below was the last reported quarterly earnings per share:06-30-2018: -0.4203-31-2018: -0.3112-31-2017: 009-30-2017: -0.60 Based on the latest filings, there is 57.80% of insider ownership and 14.60% of institutional ownership. Short-interest was 1,683,197, which was 4.83% of shares outstanding. The short-interest ratio or days-to-cover ratio was 23.94. This stock has some short interest, but it might be normal and no need to worry if long the position. I calculated the beta to be 1.54 PR Newswire: CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update Based on last reported financials, the company’s return on equity is -150.08%, return on assets is -130.11% and price-to-book is 10.04. Results are out of six: 0 : Growth Expectations Result 6 : Financial Safety Result 0 : Past Performance Result 0 : Valuation Result 0 : Dividend Safety Result 1 : Overall Result Related Tags: Biotechnology, ELOX, Eloxx Pharmaceuticals, Healthcare",0,7.0,0.2916666666666667,0.0,1053951,0.5888429986792766,1,2018-10-17 13:58:55,False
